Benzinga's Top Pre-Market Gainers

by Lisa Levin, Benzinga Editor

August 14, 2013 8:07 AM | 29 seconds read | Make a Comment

MannKind

MNKD

moved up 17.35% to $8.05 in the pre-market session after the company reported positive clinical data for AFREZZA. Brocade Communications

BRCD

soared 14.49% to $7.90 in the pre-market trading after the company reported better-than-expected fiscal third-quarter results. Osiris Therapeutics

OSIR

surged 9% to $27.73 in the pre-market session on clinical study results. GenMark Diagnostics

GNMK

shares gained 4.65% to $10.35 in the pre-market session after the company priced 7.6 million shares of common stock at $9.84.

Posted In: News Pre-Market Outlook Markets Movers Top Pre-Market Gainers

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.